FGF2 promotes Msx2 stimulated PC‐1 expression via Frs2/MAPK signaling

Journal of Cellular Biochemistry - Tập 111 Số 5 - Trang 1346-1358 - 2010
Yan Li1, Jin Liu2, Mark P. Hudson3, Sung‐Su Kim2, Nan Hatch2
1Department of Periodontics and Oral Medicine, University of Michigan, Ann Arbor, Michigan
2Department of Orthodontics and Pediatric Dentistry, University of Michigan, Ann Arbor, Michigan
3Department of Physiology and Biophysics, University of Washington, Seattle, Washington

Tóm tắt

AbstractPC‐1 is an enzymatic generator of pyrophosphate and a critical regulator of tissue mineralization. We previously showed that fibroblast growth factor‐2 (FGF2) specifically induces PC‐1 expression in calvarial pre‐osteoblasts and that this occurs via a transcriptional mechanism involving Runx2. Because aberrant FGF signaling and Msx2 activity result in similar craniofacial skeletal defects and because Msx2 is an established regulator of osteoblastic gene expression, here we investigate Msx2 as an additional mediator of PC‐1 gene expression. mRNA analysis and experiments utilizing PC‐1 gene promoter/luciferase reporter constructs demonstrate that Msx2 promotes transcription of the PC‐1 gene downstream of FGF2. Results indicate that both Msx2 and Runx2 are recruited to a conserved core Msx2 binding site within the PC‐1 gene promoter upon FGF2 stimulation, and that Msx2 and Runx2 function together to induce PC‐1 gene expression in osteoblastic cells. Here we show that FGF signaling promotes Msx2 transcriptional activity on the PC‐1 gene promoter via the Frs2/MAPK signaling pathway. To our knowledge, this is the first report of Msx2 functioning as a transcriptional enhancer downstream of FGF2 in calvarial pre‐osteoblasts. As activating mutations in FGF receptors and Msx2 result in similar craniofacial skeletal disorders, our findings support the idea that FGF signaling and Msx2 activity influence cranial osteogenesis via the same molecular mechanism. J. Cell. Biochem. 111: 1346–1358, 2010. © 2010 Wiley‐Liss, Inc.

Từ khóa


Tài liệu tham khảo

10.1016/S0002-9440(10)63172-0

10.1016/S0002-9440(10)62481-9

10.1002/jcb.21039

Barnes GL, 2003, Osteoblast‐related transcription factors Runx2 (Cbfa1/AML3) and MSX2 mediate the expression of bone sialoprotein in human metastatic breast cancer cells, Cancer Res, 63, 2631

10.1002/j.1460-2075.1995.tb00306.x

10.1016/S8756-3282(03)00222-9

10.1002/ajmg.1320470509

10.1016/S0901-5027(96)80011-7

10.1074/jbc.271.27.16422

10.1073/pnas.0405031101

Fleisch H, 1966, Effect of pyrophosphate on hydroxyapatite and its implications in calcium homeostasis, Am J Physiol, 211, 821

Franceschi RT, 2003, Multiple signaling pathways converge on the Cbfa1/Runx2 transcription factor to regulate osteoblast differentiation, Connect Tiss Res, 44, 109, 10.1080/03008200390152188

10.1074/jbc.M109.040980

10.1128/MCB.24.20.9248-9261.2004

10.1074/jbc.M604508200

10.1080/03008200500237203

10.1074/jbc.M600448200

10.1359/jbmr.081213

10.1073/pnas.142063399

10.1016/0092-8674(93)90379-5

10.2741/1593

10.1359/jbmr.1999.14.6.883

10.1152/ajpregu.2000.279.4.R1365

Johnson K, 2001, The nucleoside triphosphate pyrophosphohydrolase isozyme PC‐1 directly promotes cartilage calcification through chondrocyte apoptosis and increased calcium precipitation by mineralizing vesicles, J Rheumatol, 28, 2681

10.1002/1529-0131(200105)44:5<1071::AID-ANR187>3.0.CO;2-3

10.1359/jbmr.2003.18.6.994

10.1074/jbc.M203750200

10.1074/jbc.M404145200

10.1002/pmic.200500289

Kreiborg S, 1981, Crouzon syndrome. A clinical and roentgencephalometric study, Scan J Plast Reconstr Surg Suppl, 18, 1

10.1074/jbc.274.27.19025

10.1073/pnas.92.13.6137

10.1128/MCB.16.3.977

10.1101/gad.1276205

10.1074/jbc.272.47.29607

10.1093/hmg/4.6.1077

10.1359/jbmr.060109

10.1038/ng0994-98

10.1016/8756-3282(85)90320-5

10.1074/jbc.M210245200

10.1074/jbc.M503942200

10.1046/j.1365-2443.2001.00466.x

10.1074/jbc.M314098200

10.1083/jcb.96.1.191

10.1016/0092-8674(79)90317-9

10.1152/ajpcell.2001.281.1.C1

10.1002/art.1780370624

10.1016/j.ydbio.2005.09.011

10.1359/jbmr.1999.14.6.893

WenkertD BenignoM MackK McAlisterW MummS WhyteM.2009.Hypophosphatasia: Prevalence of Clinical Problems in 175 Pediatric Patients. American Society for Bone and Mineral Research 31st Annual Meeting Denver CO. Abstract A09001674.

10.1074/jbc.M206482200

10.1074/jbc.M206057200

10.1074/mcp.M700574-MCP200

10.1093/hmg/9.13.2001